Larimar Therapeutics, Inc. ( ($LRMR) ) has released its Q3 earnings. Here is a breakdown of the information Larimar Therapeutics, Inc. presented ...
Biohaven was seeking approval for its drug Vyglxia in the treatment of Spinocerebellar ataxia. ・The company is in the process ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback